|
Alemtuzumab
|
Visite: 145
|
|
Altretamine
|
Visite: 329
|
|
Aminoglutetimide
|
Visite: 284
|
|
L'Acido 5-Aminolevulinico
|
Visite: 238
|
|
Idrossicarbamide
|
Visite: 151
|
|
Anastrozole
|
Visite: 309
|
|
Arsenico Triossido Di
|
Visite: 264
|
|
Asparaginasi
|
Visite: 260
|
|
Bevacizumab
|
Visite: 156
|
|
Bexarotene
|
Visite: 295
|
|
Bleomicina
|
Visite: 292
|
|
Busulfan
|
Visite: 268
|
|
Capecitabina
|
Visite: 283
|
|
Carboplatino
|
Visite: 325
|
|
Carmustina
|
Visite: 321
|
|
Cetuximab
|
Visite: 195
|
|
Ciclofosfamide
|
Visite: 176
|
|
Cisplatino
|
Visite: 189
|
|
La citarabina
|
Visite: 155
|
|
Cladribina
|
Visite: 183
|
|
Chlorambucil
|
Visite: 280
|
|
Chlormethinum
|
Visite: 283
|
|
Dacarbazina
|
Visite: 146
|
|
Dactinomicina
|
Visite: 191
|
|
Daunorubicina
|
Visite: 149
|
|
Docetaxel
|
Visite: 148
|
|
Doxorubicina
|
Visite: 312
|
|
Epirubucin
|
Visite: 140
|
|
Erlotinib
|
Visite: 145
|
|
Etoposide
|
Visite: 170
|
|
Exemestano
|
Visite: 198
|
|
Fluorouracile Topico Soluzione
|
Visite: 130
|
|
Fluorouracile
|
Visite: 201
|
|
Gemcitabina
|
Visite: 136
|
|
Idarubicina-Hcl
|
Visite: 167
|
|
Ifosfamide
|
Visite: 133
|
|
Melfalan
|
Visite: 131
|
|
Mercaptopurina
|
Visite: 173
|
|
Methotrexate
|
Visite: 226
|
|
Mitomicina
|
Visite: 227
|
|
Mitoxantrone
|
Visite: 141
|
|
Oxaliplatino
|
Visite: 120
|
|
Paclitaxel
|
Visite: 163
|
|
Pentostatina
|
Visite: 164
|
|
Procarbazina
|
Visite: 140
|
|
Rituximab
|
Visite: 187
|
|
Teniposide
|
Visite: 135
|
|
Tioguanina
|
Visite: 120
|
|
Tiotepa
|
Visite: 123
|
|
Trastuzumab
|
Visite: 170
|
|
Tretinoin Orale
|
Visite: 169
|
|
Vinblastina
|
Visite: 143
|
|
Vincristina
|
Visite: 134
|
|
Vinorelbine Tartrate
|
Visite: 154
|
|
Everolimus
|
Visite: 150
|
|
Imatinib Mesilato
|
Visite: 150
|
|
Nilotinib
|
Visite: 185
|
|
Dasatinib
|
Visite: 141
|
|
Pazopanib
|
Visite: 127
|
|
Ipilimumab
|
Visite: 128
|
|
Nivolumab
|
Visite: 169
|
|
Brentuximab Vedotin
|
Visite: 156
|